Ocular Melanoma Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
DCTH | B | Delcath Systems, Inc. | 4.92 | |
IOVA | D | Iovance Biotherapeutics, Inc. | -0.68 |
Related Industries: Biotechnology Medical Devices
Related Stock Lists:
Medicine
Melanoma
Oncology
Adoptive Cell Transfer
Antineoplastic Drugs
Biopharmaceutical
Breast And Lung Cancer
Cancer
Cancer Cell
Cancer Immunotherapy
Cancer Immunotherapy Product
Cancer Treatment
Carcinoma
Cell Therapy
Checkpoint Inhibitor
Chemotherapy
Chloride
Cholangiocarcinoma
Clinical Development
Clinical Medicine
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
WDNA | D | WisdomTree BioRevolution Fund | 3.32 | |
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 3.29 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.28 | |
INNO | C | Harbor Disruptive Innovation ETF | 1.19 | |
CNCR | D | Loncar Cancer Immunotherapy ETF | 1.18 |
Compare ETFs
Related Industries:
Biotechnology
Medical Devices
Related Stock Lists:
Medicine
Melanoma
Oncology
Adoptive Cell Transfer
Antineoplastic Drugs
Biopharmaceutical
Breast And Lung Cancer
Cancer
Cancer Cell
Cancer Immunotherapy
Cancer Immunotherapy Product
Cancer Treatment
Carcinoma
Cell Therapy
Checkpoint Inhibitor
Chemotherapy
Chloride
Cholangiocarcinoma
Clinical Development
Clinical Medicine
- Ocular Melanoma
Uveal melanoma is a cancer (melanoma) of the eye involving the iris, ciliary body, or choroid (collectively referred to as the uvea). Tumors arise from the pigment cells (melanocytes) that reside within the uvea giving color to the eye. These melanocytes are distinct from the retinal pigment epithelium cells underlying the retina that do not form melanomas. When eye melanoma is spread to distant parts of the body, the 5-year survival rate is about 15%.
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles